Pipeline Setback at Bristol-Myers
Yahoo/Zacks
Inhibitex Shares Whipsawed by Cautious Analyst Comment
TheStreet.com
4 Reasons Inhibitex Is No Longer A Good Buy
Seeking Alpha
Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial
Yahoo/Fly on the Wall
Inhibitex's Future Looks Promising
Seeking Alpha
Inhibitex Investors: Why Shares Popped 115%
Motley Fool

